Skip to main content
Christopher Porter, MD, Pediatric Hematology & Oncology, Atlanta, GA

Christopher Clayton Porter MD

Pediatric Hematology & Oncology•Atlanta, GA

Associate Professor, Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta and Emory University School of Medicine

Join to View Full Profile

  • 1760 Haygood DriveHealth Sciences Research BuildingAtlanta, GA 30322

  • Phone+1 404-727-4881

Dr. Porter is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Porter's Full ProfileAlready have an account?

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Hematology/Oncology, 2002 - 2007
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Pediatrics, 1999 - 2002
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 1999
  • Vanderbilt University
    Vanderbilt UniversityB.A., Psychology, Cum Laude, 1994

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2016 - 2027
  • CO State Medical License
    CO State Medical License 2002 - 2017
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Spotlight Health Scholar, Aspen Ideas Festival 2015
  • CureSearch Young Investigator Award in Acute Lymphoblastic Leukemia 2012
  • Hyundai Hope on Wheels Scholar Award 2011

Publications & Presentations

PubMed

Journal Articles

  • Irradiation selects for p53 mutation in hematopoietic progenitors  
    Marusyk A, Porter CC, Zaberezhnyy V, DeGregori J, PLoS Biology, 1/1/2010
  • Bcl-6 over-expression correlates with monomorphic histology in children with post-transplantation lymphoproliferative disease  
    Porter CC, Liang X, Gralla J, McGavran L, Albano EA, J Pediatr Hematol/Oncol, 1/1/2008

Books/Book Chapters

  • Current Pediatric Diagnosis and Treatment. 
    Chapter: Neoplastic Diseases. 
    Albano EA, Basal M, Porter CC, Foreman NK, Stork LEditors: Hay WW, Levin MJ, Sondheimer JM and RR Deterding.Appleton and Lange, New York, NYEdition 17th,2005

Abstracts/Posters

  • Germline Mutations in ETV6 are Associated with In Vivo cytoplasmic Localization of ETV6 and Cause Transcriptional Dysregulation of Interferon Response Genes
    Christopher C. Porter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • ETV6 represses Pax5 in early B cell development.
    Jones CL, Kirkpatrick G, Fleenor CJ, Welsh S, Noetzli L, Fosmire S, Baturin D, Rowley J, Di Paola J, Hagman JR, Porter CC, Blood, 1/1/2016
  • IFN-y Alters the Expression of Diverse Immunity Related Genes in a Cell Culture Model of Maturing Bone Marrow Neutrophils.
    Ellison MA, Gearheart CM, Porter CC and Ambruso DR, Blood, 1/1/2016

Lectures

  • Cancer and the immune system. 
    1/1/2016
  • Introduction to hematopoietic malignancies 
    1/1/2016
  • Chronic myeloid leukemia 
    1/1/2016

Other

  • Germline mutations associated with leukemias. (Invited Review) 
    Porter CC, Hematology, American Society of Hematology Education Program
    1/1/2016
  • Back to the Bedside. 
    Porter CC, ASH News Daily
    1/7/2010
  • The promise of gene therapy that WAS is now. 
    CC Porter, ASH News Daily
    1/6/2010

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Christopher Porter, Dr. Christopher Porter, MD, Dr. C Porter, Dr. Christopher Clayton Porter